[HTML][HTML] A novel intra-tumoral drug delivery carrier for treatment of oral squamous cell carcinoma

SA Elsaady, MN Aboushelib, E Al-Wakeel… - Scientific Reports, 2023 - nature.com
The treatment of oral squamous cell carcinoma (OSCC) includes systemic chemotherapy
and is associated with aggressive side effects on patients. This study evaluated a new intra …

A novel intra-tumoral drug delivery carrier for treatment of oral squamous cell carcinoma

SA Elsaady, MN Aboushelib, E Al-Wakeel… - Scientific …, 2023 - ui.adsabs.harvard.edu
The treatment of oral squamous cell carcinoma (OSCC) includes systemic chemotherapy
and is associated with aggressive side effects on patients. This study evaluated a new intra …

[HTML][HTML] A novel intra-tumoral drug delivery carrier for treatment of oral squamous cell carcinoma

SA Elsaady, MN Aboushelib, E Al-Wakeel… - Scientific …, 2023 - ncbi.nlm.nih.gov
The treatment of oral squamous cell carcinoma (OSCC) includes systemic chemotherapy
and is associated with aggressive side effects on patients. This study evaluated a new intra …

A novel intra-tumoral drug delivery carrier for treatment of oral squamous cell carcinoma.

SA Elsaady, MN Aboushelib, E Al-Wakeel… - Scientific …, 2023 - search.ebscohost.com
The treatment of oral squamous cell carcinoma (OSCC) includes systemic chemotherapy
and is associated with aggressive side effects on patients. This study evaluated a new intra …

A novel intra-tumoral drug delivery carrier for treatment of oral squamous cell carcinoma.

SA Elsaady, MN Aboushelib, E Al-Wakeel… - Scientific …, 2023 - europepmc.org
The treatment of oral squamous cell carcinoma (OSCC) includes systemic chemotherapy
and is associated with aggressive side effects on patients. This study evaluated a new intra …

A novel intra-tumoral drug delivery carrier for treatment of oral squamous cell carcinoma

SA Elsaady, MN Aboushelib, E Al-Wakeel… - Scientific …, 2023 - pubmed.ncbi.nlm.nih.gov
The treatment of oral squamous cell carcinoma (OSCC) includes systemic chemotherapy
and is associated with aggressive side effects on patients. This study evaluated a new intra …